Zimbabwe has withdrawn from negotiations on a US$350 million health agreement, citing sovereignty concerns, while the US ...
Zimbabwe explains why President Mnangagwa rejected US$367 million US health funding for HIV, TB, and malaria treatment. Government spokesman Nick Mangwana cites sovereignty concerns over demands for ...
The US launches long-acting HIV prevention drug lenacapavir in Zimbabwe, aiming to support thousands of people.
The United States Government announced US$45 million in funding to respond to the critical food security situation in the upcoming lean season between October 2019 and March 2020 in Zimbabwe.
The United States is winding down a major health aid program to Zimbabwe following failed negotiations over data sharing and sovereignty concerns. The proposed USD 367 million deal aimed to support ...